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Introduction: The goal of this large population-based study was to examine the socio-
economic implications of cancer survivorship.
Methods: Individuals alive and diagnosed with colorectal cancer and melanoma between
1998 and 2007 or Hodgkin lymphoma, non-Hodgkin lymphoma or multiple myeloma
between 1999 and 2008 as registered in the Eindhoven Cancer Registry received a question-
naire on work changes and problems with obtaining a new (or extended) health care insur-
ance, life insurance or a home loan; 70% (n = 2892) responded.
Results: Results showed that 28% of all cancer patients experienced changes in their work
situation after cancer. Most of them switched to part-time work or stopped working
entirely. Patients (3.4%) who tried to obtain a different or upgrade their health care insur-
ance experienced problems and in most cases, these were eventually resolved. Problems
with life insurance were somewhat more common with 18% of those who tried to obtain
a life insurance experiencing problems. The majority of these patients was rejected by
the insurance company (61%) or was accepted at a higher premium (22%). Of the 21%
who tried to obtain a home loan, 9% experienced problems. However, 22.2% got accepted
eventually, 27.8% got accepted but at a higher mortgage payment and 22.2% got rejected
but were eventually accepted by another bank.
Conclusions: Almost a third of cancer survivors experienced changes in their work situation
after cancer. Problems with obtaining health insurance, life insurance and home loans
were also common.
 2011 Elsevier Ltd.Open access under the Elsevier OA license. 1. Introduction
Advances in early diagnoses and effective treatment of cancer
have led to an increasing number of cancer survivors.1,2 The
effects of cancer and its treatment on the physical andmentalpartment of Medical Psy
s (F. Mols).
he Elsevier OA license. health status of cancer survivors is an important research to-
pic nowadays. Only a few studies take notice of more practical
problems that cancer survivors might experience after diag-
nosis and treatment, like socio-economic implications of
survivorship. A recent meta-analysis showed that cancerchology and Neuropsychology, Tilburg University, PO Box 90153,
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ment.3,4 In addition, to additional health care costs, cancer
survivors may also experience financial problems like obtain-
ing health care insurance, life insurance and home loans.5–7
Although these financial problems can have a major im-
pact on the lives of cancer survivors, and these problems
are often not justified according to patients’ current health
status, research on these topics is still scarce8 and is most
often done among small specific subgroups of survivors.5–7
Therefore, the goal of this large population-based study
was to examine whether survivors of colorectal cancer, mel-
anoma, Hodgkin lymphoma, non-Hodgkin lymphoma or
multiple myeloma experienced changes in their work situa-
tion or experienced problems with obtaining a new (or ex-
tend an existing) health care insurance, life insurance or a
home loan.
2. Materials and methods
2.1. Setting and participants
In this study, data from several large population-based sur-
veys on survivors of colorectal cancer, melanoma, Hodgkin
lymphoma, non-Hodgkin lymphoma and multiple myeloma
from the PROFILES registry were used.9 These surveys were
conducted to evaluate different patient reported outcomes
among cancer survivors.
The Eindhoven Cancer Registry (ECR), which is part of the
Comprehensive Cancer Centre South, compiles data of all
individuals newly diagnosed with cancer in the southern part
of the Netherlands, an area with 10 hospitals serving 2.3 mil-
lion inhabitants.10 All individuals diagnosed with colorectal
cancer and melanoma between 1998 and 2007 or Hodgkin
lymphoma, non-Hodgkin lymphoma or multiple myeloma
between 1999 and 2008 as registered in the ECR were eligible
for participation. Due to the large number of colorectal cancer
survivors (N = 5399) a weighted random selection of 2219 pa-
tients based on tumour, sex, and year of diagnosis was
made.11 Due to the large number of melanoma survivors,
we only selected patients diagnosed in 3 out of 10 regional
hospitals.12,13
After excluding patients with cognitive impairment, who
had unverifiable addresses, or had died prior to start of study
(according to the ECR, hospital records, and the Central Bu-
reau for Genealogy which collects information on all de-
ceased Dutch citizens via the civil municipal registries), data
collection started between 2008 and 2009. All surveys were
approved by a local certified Medical Ethics Committee.
2.2. Data collection
Survivors were informed of the surveys via a letter from their
(ex)-attending specialist. The letter explained that by com-
pleting and returning the enclosed questionnaire, patients
consented to participate and agreed to the linkage of the
questionnaire data with their disease history in the ECR. Pa-
tients were reassured that non-participation had no conse-
quences on their follow-up care or treatment. Non-
respondents were sent a reminder letter and the question-
naire within 2 months.2.3. Measures
Survivors’ sociodemographic and clinical information were
available from the ECR. The ECR routinely collects data on tu-
mour characteristics, including date of diagnosis, tumour
grade,14 clinical stage,14 primary treatment, and patient back-
ground characteristics including date of birth and comorbid-
ity at the time of diagnosis. Socioeconomic status was
determined by an indicator developed by Statistics Nether-
lands.15 Questions on current comorbidity, marital status,
educational level, and current occupation were added to the
questionnaire. We also added questions on problems with
insurance and home loans. Data on if and how these prob-
lems were eventually solved were only available for patients
with colorectal cancer, Hodgkin lymphoma, non-Hodgkin
lymphoma, and multiple myeloma, and not for melanoma
survivors.2.4. Statistical analyses
Routinely collected data from the ECR on patient and tumour
characteristics enabled us to compare the group of respon-
dents, non-respondents and patients with unverifiable ad-
dresses, using t-tests for continuous variables and chi-
square analyses for categorical variables.
Percentages of patients experiencing changes in work sit-
uationswere calculated among those younger than 65 at diag-
nosis since that is the age of retirement in the Netherlands. In
addition, percentages of patients experiencing problems with
insurance and home loans were calculated.
All statistical test’s were two-sided and considered
significant if p < 0.05. All statistical analyses were performed
using SAS (version 9.2 for Windows, SAS institute Inc., Cary,
NC).
3. Results
3.1. Demographic and clinical characteristics
The response rate was high, with 70% of the 4123 cancer sur-
vivors returning a completed questionnaire. As described in a
previous paper, patients with unverifiable addresses in gen-
eral were younger, with more years since diagnosis, and they
were less often treated with surgery, and less often diagnosed
with colorectal cancer.16 Non-respondents were less often
treatedwith radiotherapy or chemotherapy. In total, 2892 can-
cer survivors were included in the final analyses (mean age
64.3). The majority of those respondents was male (53.9), mar-
ried (76%), had a medium educational level (60%), was not
employed (75%), and had a medium or high socio-economic
status (79%) (Table 1).
3.2. Work changes
The majority of patients younger than 65 at time of diagnosis
(n = 913; 72.2%) stated that their work situation had not chan-
ged due to cancer. However, of those who did experience
changes (n = 351; 27.8%), 76 (21.7%) patients chose to stop
working themselves, 108 patients (30.8%) indicated that they
Table 1 – Demographic and clinical characteristics of those reporting socio-economic problems.
N (%)
Health care insurance Life insurance Mortgage Total group
N = 60 (3.4%) N = 119 (20.3%) N = 53 (9.5%) N = 2892 (70.1%)
Age (at time of survey) (mean ± standard
deviation (SD))
56.4 (14.9) 48.9 (14.3) 46.2 (14.1) 64.3 (13.1)
Years since diagnosis (mean ± SD) 5.6 (2.5) 5.6 (2.5) 5.8 (2.3) 4.6 (2.6)
Gender
Male 36 (60.0) 67 (56.3) 34 (64.2) 1558 (53.9)
Female 24 (40.0) 52 (43.7) 19 (35.9) 1334 (46.1)
Cancer type
Melanoma 12 (20.0) 29 (24.4) 15 (28.3) 556 (71.9)
Colorectal cancer 18 (30.0) 28 (23.5) 10 (18.9) 1353 (71.9)
Non-Hodgkin 20 (33.3) 12 (22.6) 32 (26.9) 714 (67.3)
Hodgkin 7 (11.7) 14 (26.4) 25 (21.0) 150 (67.6)
Multiple Myeloma 3 (5.0) 5 (4.2) 2 (3.8) 119 (64.7)
Stage (at diagnosis)
I 13 (43.4) 30 (52.6) 12 (48.0) 781 (40.9)
II 11 (36.7) 14 (24.6) 7 (28.0) 622 (32.6)
III 5 (16.7) 11 (19.3) 5 (20.0) 425 (22.3)
IV 1 (3.3) 1 (1.8) 1 (4.0) 69 (3.6)
Primary treatment
Surgery 30 (50.0) 57 (47.9) 25 (47.2) 1892 (65.4)
Radiotherapy 18 (30.0) 36 (30.3) 13 (24.5) 646 (22.4)
Chemotherapy 26 (43.3) 57 (47.9) 27 (50.9) 1035 (35.9)
Comorbiditya
None 26 (43.3) 72 (60.5) 32 (60.4) 1304 (45.1)
1 13 (21.7) 21 (17.7) 8 (15.1) 649 (22.4)
2+ 21 (35.0) 26 (21.9) 13 (24.5) 939 (32.5)
Most frequent comorbid conditions
Back pain 17 (28.3) 15 (12.6) 9 (17.0) 552 (19.1)
High blood pressure 10 (16.7) 16 (13.5) 6 (11.3) 617 (21.3)
Osteoarthritis 9 (15.0) 10 (8.4) 5 (9.4) 563 (19.5)
Marital status
Married 50 (84.8) 103 (87.3) 46 (88.5) 2158 (75.9)
Never married 6 (10.2) 12 (10.2) 3 (5.8) 529 (18.6)
Divorced/widowed 3 (5.1) 3 (2.5) 3 (5.8) 157 (5.5)
Education levelb
Low 11 (18.3) 19 (16.1) 8 (15.4) 559 (19.8)
Medium 34 (56.7) 66 (55.9) 31 (59.6) 1703 (60.4)
High 15 (25.0) 33 (28.0) 13 (25.0) 558 (19.8)
Current occupation
Employed 26 (45.6) 74 (65.5) 32 (65.3) 697 (25.1)
Not working/retired 31 (54.4) 39 (34.5) 17 (34.7) 2078 (74.9)
Socioeconomic status
Low 11 (20.0) 24 (21.6) 7 (14.9) 570 (20.6)
Medium 28 (50.9) 59 (53.2) 27 (57.5) 1118 (40.4)
High 16 (29.1) 28 (25.2) 13 (27.7) 1078 (39.0)
a Adapted self-administered comorbidity questionnaire.19
b Education: low (no or primary school); medium (lower general secondary education or vocational training); high (pre-university education,
high vocational training, university).
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said that they had been fired due to cancer, and 23 (6.6%)
patients retired early due to cancer. In addition, 97 (27.6%) pa-
tients switched to part-time work, six patients (1.7%) worked
more hours after their diagnosis, and 16 patients (4.6%) fol-
lowed occupational retraining due to cancer.3.3. Problems with insurance and home loans
Demographic and clinical characteristics of those reporting
socio-economic problems are described in Table 1. One third
of patients did not try to obtain a different or more comple-
mentary health care insurance (e.g. an upgrade) (n = 1014;
2040 E U R O P E A N J O U R N A L O F C A N C E R 4 8 ( 2 0 1 2 ) 2 0 3 7 –2 0 4 236.7%) after their cancer diagnosis. However, 1748 patients did
try and 60 (3.4%) of them experienced problems (Fig. 1).
Regarding the resolution of these problems in these patients
(excluding the melanoma patients), 19 (42.2%) survivors got
accepted eventually, 13 (28.9%) got accepted at a higher pre-
mium, 7 (15.6%) got rejected by the insurance company, and
6 (13.3%) got rejected but were eventually accepted by another
company.
On obtaining life insurance after cancer diagnosis, 586
(22.1%) survivors tried and of these, 119 patients (20.3%) expe-
rienced problems (Fig. 1). Of those patients who did experi-
ence problems with getting a life insurance, nine patients
(11.1%) got accepted eventually, 18 (22.2%) got accepted at a
higher premium, 49 (60.5%) got rejected by the insurance
company and five (6.2%) got rejected but were eventually ac-
cepted by another company.
Of the 557 (21.2%) survivors who tried to get a home loan,
53 patients (9.5%) experienced problems (Fig. 1). Of these pa-
tients, eight patients (22.2%) got accepted eventually, 10
(27.8%) got accepted but they pay a higher premium, 10
(27.8%) got rejected by the bank and eight (22.2%) got rejected
but were eventually accepted by another bank.“Did you experience problems obtaining a different or 
because of your cancer?” 
 Yes N=60 (3.4%) How were
    Got accep
    Got accep
    Got reject
No N=1688 (96.6%)   Got accep
*This overview only shows the patients that actually tried (n=
-------------------------- -------------------- --------------------
“Did you experience problems obtaining life insurance
 Yes N=119 (20.3%) How were
    Got accep
    Got accep
    Got reject
No N=467 (79.7%)   Got accep
*This overview only shows the patients that actually tried (n=
-------------------------- -------------------- --------------------
“Did you experience problems obtaining a mortgage 
 Yes N=53 (9.5%) How were
    Got accep
    Got accep
    Got reject
No N=504 (90.5%)   Got accep
*This overview only shows the patients that actually tried (n=
Fig. 1 – Overview of socio-economic implic4. Discussion
The present study showed that of the 28% cancer patients
experienced changes in their work situation after cancer.
Most of them switched to part-time work or stopped working
entirely.
These percentages were also found in two Dutch popula-
tion-based studies among long-term Hodgkin and non-Hodg-
kin lymphoma survivors.17,18
No more than 3.4% of patients who tried to obtain a differ-
ent or more coverage of their health care insurance experi-
enced problems and in most cases, these were eventually
resolved. Problems with life insurance were more common
with 20.3% of those who tried to obtain a life insurance expe-
riencing problems. The majority of these patients got rejected
by the insurance company (61%) or were accepted but had to
pay a higher premium (22%). The number of patients experi-
encing problems obtaining health insurance or life insurance
was mostly in line with the literature5,7,17,18 although two
studies among Hodgkin and non-Hodgkin lymphoma survi-
vors reported higher rates of patients experiencing problems
with health insurance (25 and 12%, respectively) and lifemore complem entary health care insurance  
 these problems solved? 
ted     N=19 (42.2%) 
ted but pay an additional fee N=13 (28.9%) 
ed     N=7 (15.6%) 
ted by another company  N=6 (13.3%) 
1748). 
-------------------- -------------------- ------------------ 
 because of your cancer?*” 
 these problems solved? 
ted     N=9 (11.1%) 
ted but pay an additional fee N=18 (22.2%) 
ed     N=49 (60.5%) 
ted by another company  N=5 (6.2%) 
586). 
-------------------- -------------------- ------------------ 
because of your cancer?” 
 these problems solved? 
ted    N=8 (22.2%) 
ted but pay an additional fee N=10 (27.8%) 
ed     N=10 (27.8%) 
ted by another company  N=8 (22.2%) 
557) 
ations of cancer survivorship problems.
E U R O P E A N J O U R N A L O F C A N C E R 4 8 ( 2 0 1 2 ) 2 0 3 7 –2 0 4 2 2041insurance (38 and 60%).17,18 These differences with previous
studies were still present after doing separate analyses for
Hodgkin and non-Hodgkin lymphoma survivors within our
cohort (data not shown). This difference might be explained
by a change in the rules and regulations of insurance compa-
nies in the past years since the lymphoma survivors in the
current cohort were diagnosed between 1999 and 2008 while
the lymphoma survivors in the two described studies were
diagnosed between 1989 and 1998.
Survivors also experienced problems with home loans. Of
the 21.2% who tried to obtain a home loan, 9.5% experienced
problems. This percentage is quite comparable to two small
studies where problems were reported by 2% of hereditary
non-polyposis colorectal cancer mutation carriers,5 and 6%
of melanoma survivors.7 However, two other studies among
Hodgkin and non-Hodgkin lymphoma survivors in the Neth-
erlands showed much higher rates of problems with obtain-
ing a home loan among those who actually tried (63% and
73%, respectively).17,18 Differences might be explained by a
shift in bank rules and regulations over the past decades.
The present study has some limitations that should be
mentioned. Although information was present concerning
the initial cancer and treatment characteristics of the non-
respondents and patients of whom the addresses could not
be verified, whether non-respondents declined to participate
in the study because of poor health remains unknown. Also,
the cross-sectional design of our study limits the determina-
tion of causal association between cancer survivorship and
occupational and financial problems. Despite these limita-
tions, the present study provides an important contribution
to the limited data available on work problems, and problems
with obtaining insurance and home loans in cancer survivors.
Since this is a population-based study among a large group of
patients with a high response rate, extrapolating these results
to the larger population of cancer survivors seems justified.
These results call for further research on the socio-economic
implications of cancer survivorship among patients followed
over a longer period of time since occupational problems
and financial problems can have a major impact on the lives
of those who experienced these problems and because these
problems are most often not justified according to patients
current health status.
In conclusion, almost a third of cancer survivors experi-
enced changes in their work situation after cancer. Most of
them switched to part-time work or stopped working entirely.
In addition, problems with obtaining health insurance, life
insurance and home loans were less common, but still one
in five experienced problems obtaining a life insurance. More
attention should be paid and more information should be gi-
ven to patients on the socio-economic implications of cancer
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